Here’s a breakdown of the key details from the provided text, focusing on the reasons for the stock decline and UnitedHealth’s performance:
Key Takeaways:
* Massive Stock Drop: UnitedHealth shares plummeted approximately 20%, falling from $352 to around $282. This is described as one of the steepest single-day declines in the company’s history. Other Medicare Advantage players like Humana also experienced significant drops.
* Medicare Rate shock: The primary catalyst for the decline is a disappointing proposal for 2027 government payment rates for Medicare Advantage plans.This is impacting the entire industry. (Referenced in the initial link: https://www.bloomberg.com/news/articles/2026-01-27/medicare-rates-shock-spurs-90-billion-rout-in-insurance-stocks)
* UnitedHealth’s 2026 Outlook: UnitedHealth projected revenue of “greater than” $439 billion for 2026, which is below analyst expectations of around $454 billion and represents a roughly 2% decrease from the previous year. this would be the first revenue contraction as the late 1980s.
* Financial Performance (2025):
* Revenue: Full-year 2025 revenue was up 12% year-over-year at approximately $447.6 billion.Q4 2025 revenue was up over 12% at roughly $113.2 billion.
* Net Income: Net income plunged to $10 million (1 cent per share) due to restructuring charges ($1.6 billion after-tax) and other factors.
* Adjusted EPS: Adjusted earnings per share were $2.11, matching forecasts but significantly down from $6.81 a year earlier.
* Factors Affecting Results: Several factors contributed to the weaker earnings:
* Higher Medical Costs: Increased healthcare expenses.
* Change Healthcare Cyberattack: fallout from a cyberattack at their Change Healthcare unit.
* Restructuring & Portfolio Clean-up: Costs associated with restructuring and streamlining operations.
* Company Strategy: UnitedHealth is focusing on:
* Core Markets: Refocusing on their primary areas of business.
* Pricing: Tightening pricing to account for rising medical costs.
* Optum Streamlining: Streamlining operations within Optum under new leadership.
* Future Outlook: Despite the near-term challenges, UnitedHealth is guiding for at least $17.75 in adjusted EPS for 2026, suggesting high-single-digit profit growth even with declining revenue. They believe these changes will lead to improved earnings quality and growth in the future.
In essence, the market is reacting negatively to the lower-than-expected revenue guidance for 2026, driven by regulatory pressures, and the impact of the Medicare Advantage rate changes, despite UnitedHealth’s efforts to reposition the business for long-term stability.
